#124 IT: PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology

#124 IT: PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology

Monday, June 17, 2024 12:55 PM to 1:25 PM · 30 min. (US/Pacific)
Exhibit Hall Theater #2
19: InnovationTheaters

Information

The proliferation of real-world data (RWD) sources and advancements in technology (e.g.,artificial intelligence (AI), wearables) have fueled the use of real-world evidence (RWE)in drug development. Globally diverse, trusted data sources and impactful AI and digital technologies provide faster, more comprehensive curated data for optimized study design and analysis. This intersection provides invaluable insights to help decision makers make smarter, faster decisions to advance and optimize product development.
PPD, part of Thermo Fisher Scientific1327PPD clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, we serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, we apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies. For more information, visit thermofisher.com/ppd.

Log in